Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience

Annals of Surgical Oncology

Volumn 14, Issue 2, 2007, Pages 646-651

  Soran, Atilla ^a   Falk, Jeffrey ^a   Bonaventura, Marguerite ^a   Keenan, Donald ^a   Ahrendt, Gretchen ^a   Johnson, Ronald ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Contralateral; Mastectomy; Prophylactic; Sentinel lymph node

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER STAGING; CARCINOMA IN SITU; DISEASE CLASSIFICATION; DUCTAL CARCINOMA IN SITU; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; MULTIPLE CANCER; OCCULT CANCER; PROPHYLAXIS; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TIME SERIES ANALYSIS;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 33846614550     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9264-9     Document Type: Article

References (28)

1. http://www.cancer.org/downloads/stt/CAFF06EsCsMc.pdf.
2. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23:7703-20.
3. Peralta EA, Ellenhorn JD, Wagman LD, et al. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 2000; 180:439-45.
4. Boughey, JC, Khakpour N, Meric-Bernstam F, et al. Routine use of sentinel lymph node surgery in prophylactic mastectomy is not warranted. Ann Surg Oncol (Suppl) 2006; 13:P64, page 53.
5. Dupont EL, Kuhn MA, McCann C, et al. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 2000; 180:274-7.
6. Cripe MH, Lehr A, Beran L, Liang W, Sickle-Santanello B. Incidence of occult contralateral breast cancer detected by magnetic resonance imaging. Ann Surg Oncol (Suppl) 2006; 13:26,P195, page 90.
7. Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 2004; 101:1977-86.
8. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62:676-89.
9. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336:1401-8.
10. Scott CI, Iorgulescu DG, Thorne HJ, Henderson MA, Phillips KA. Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy. Clin Genet 2003; 64:111-21.
11. Bilimoria M, Morrow M. The woman at increased risk for breast cancer: evaluation and management strategies. CA Cancer J Clin 1995; 45:263-78.
12. Hartmann LC, Schnaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999; 340:77-84.
13. Kroll SS, Miller M, Schusterman M, et al. Rationale for elective contralateral mastectomy with immediate bilateral reconstruction. Ann Surg Oncol 1994; 1:457-61.
14. Barone JE, Tucker JB, Perez JM, Odom SR, Ghevariya V. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Am Surg 2005; 71:66-70.
15. Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol. B-27.JCO 2005; 23:2694-702.
16. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van't Veer L, Garber JE, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004; 22:1055-62.
17. Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001; 345:159-64.
18. Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, et al. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices. Arch Intern Med 2005; 165:516-20.
19. Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, et al. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 2003; 21:1675-81.
20. Kern KA, Borgen P, Mamounas EP, McMasters KM, Singletary E. Contemporary surgery 2005; 6:63-72.
21. Lee JM, Dominguez F, Gadd M, et al. Detecting occult breast cancer in prophylactic mastectomies: sentinel node biopsy vs pre-operative MRI. Ann Surg Oncol 2006; (Suppl) 13-26, P26, page 9.
22. Sood A, Youssef IM, Heiba SI, et al. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med 2004; 29:698-702.
23. Newman EA, Cimmino VM, Sabel MS, et al. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol 2006; 13:52-7.
24. Port ER, Fey J, Gemignani ML, et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 2002; 195:167-72.
25. Bass SS, Cox CE, Ku NN, Reintgen DS. The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 1999; 189:183-94.
26. Cody HS. Management of the axilla in early stage breast cancer: will sentinel node biopsy end the debate? J Surg Oncol 1999; 71:137-39.
27. Cox CE, Bass SS, McCann CR, et al. Lymphatic mapping and sentinel node biopsy in patients with breast cancer. Annu Rev Med 2000; 51:525-42.
28. Leidenius M, Leivonen M, Vironen J, von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 2005; 92:23-31.